2024-11-13T13:53:21-06:00 2023-12-31 410746749 CLIFTONLARSONALLEN LLP 901 NORTH GLEBE ROAD SUITE 200 ARLINGTON VA 22203 990 2023-01-01 464555214 PHARMACEUTICAL PRODUCT STEWARDSHIP WORK GROUP PHAR 2024953131 1800 M STREET NW SUITE 400 SOUTH WASHINGTON DC 20036 ANNE VOGEL-MARR EXECUTIVE DIRECTOR 2024953131 2024-11-11 1 0 ROBERT WILLIAMS P01345960 5712279500 2024-11-11 2023 2024-10-15 13:58:12Z ANNE VOGEL-MARR 1800 M STREET NW SUITE 400 SOUTH WASHINGTON DC 20036 4070019 0 X WWW.PPSWG.ORG X 2014 DC PROVIDE INFRASTRUCTURE, GUIDANCE AND SUBJECT MATTER EXPERTISE TO SUPPORT MEMBER COMPLIANCE WITH LEGISLATIVE MANDATES FOR THE PROPER DISPOSAL OF UNWANTED HOUSEHOLD MEDICINES AND HOME GENERATED SHARPS AND IMPROVE AWARENESS OF EXISTING PHARMACEUTICAL DISPOSAL OPTIONS. 9 9 0 9 0 0 0 0 4554149 3955177 20830 100242 0 14600 4574979 4070019 0 0 0 0 0 0 0 0 0 3991401 3741383 3991401 3741383 583578 328636 23702827 22293395 19684739 17946671 4018088 4346724 X FACILITATE THE APPROPRIATE AND EFFICIENT DISPOSAL OF UNWANTED HOUSEHOLD MEDICINES AND HOME GENERATED SHARPS BY PROVIDING INFRASTRUCTURE, GUIDANCE, AND SUBJECT MATTER EXPERTISE TO SUPPORT MEMBER COMPLIANCE AND IMPROVE AWARENESS OF EXISTING PHARMACEUTICAL DISPOSAL OPTIONS. 0 0 COMMUNICATION AND PROGRAM ADMINISTRATION: PPSWG PROVIDES A FORUM TO DEVELOP CONSENSUS AMONG PHARMACEUTICAL AND SHARPS MANUFACTURERS AND A FRAMEWORK FOR ADDRESSING COMPLIANCE WITH HOUSEHOLD-GENERATED UNWANTED PHARMACEUTICAL AND SHARPS PRODUCTS STEWARDSHIP LEGISLATION THROUGH ACTIVE MEMBER ENGAGEMENT. PPSWG RAISES PUBLIC AWARENESS ABOUT THE APPROPRIATE DISPOSAL METHODS FOR HOUSEHOLD-GENERATED UNWANTED PHARMACEUTICAL AND SHARPS PRODUCTS. 0 0 0 1 0 0 0 0 0 1 0 0 0 1 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 1 12 0 1 0 0 0 0 0 0 0 0 0 X 9 9 0 1 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 0 0 0 X ROBIN BLACKMAN 2024953131 1800 M STREET NW SUITE 400 SOUTH WASHINGTON DC 20036 X COLIN CHILES CHAIR 0.40 X X 0 0 0 ANNE MURRAY PAST CHAIR 0.40 X X 0 0 0 BARBARA MORROW VICE CHAIR 0.40 X X 0 0 0 SHAWN BROWN SECRETARY/TREASURER 0.40 X X 0 0 0 BEENA PATEL DIRECTOR 0.40 X 0 0 0 STEVE GIULI DIRECTOR 0.40 X 0 0 0 KATE KULESHER DIRECTOR 0.40 X 0 0 0 DREW REAVIS DIRECTOR 0.40 X 0 0 0 TRAVIS SHAW DIRECTOR 0.40 X 0 0 0 ANNE VOGEL-MARR EXECUTIVE DIRECTOR 40.00 X 0 0 0 MELISSA LETENDRE VICE PRESIDENT, FINANCE 40.00 X 0 0 0 0 0 0 0 0 0 0 ASSN MANAGEMENT STRATEGIES INC 1800 M STREET NW STE 400S WASHINGTON DC 20036 MANAGEMENT 1950000 PUBLIC AFFAIRS COMPANY 333 S SEVENTH STREET MINNEAPOLIS MN 55402 EDUCATION AND OUTREACH 291666 BEVERIDGE & DIAMOND PC 1900 N STREET NW SUITE 100 WASHINGTON DC 20036 LEGAL COUNSEL 272030 VALERIA SCHLITT ASSOCIATES 441 STATION AVE HADDONFIELD NJ 08033 MYOLDMEDS WEBSITE MAINTENANCE 244500 SHIFT PARADIGM 11612 BEE CAVES ROAD AUSTIN TX 78738 MYOLDMEDS WEBSITE MAINTENANCE 216000 6 MEMBERSHIP DUES 561000 3955177 3955177 3955177 100242 100242 MISCELLANEOUS INCOME 900099 14600 14600 14600 4070019 3955177 0 114842 1950000 331809 44675 50000 139832 2396 559788 17081 20533 75450 13700 EDUCATION AND OUTREACH 291666 DATA COLLECTION & ANALY 152571 SPECIAL PROJECTS 34717 COST ALLOCATION 28317 28848 3741383 250000 275175 21742197 21800814 1578519 137411 27206 50540 827339 797884 104905 29455 23702827 22293395 424486 130459 2098132 3029951 17162121 14786261 19684739 17946671 X 4018088 4346724 4018088 4346724 23702827 22293395 328636 0 X 0 1 X 1 0 0 0 0 3955177 50000 50000 50000 PART III-A, LINE 2 PPSWG HAS ENGAGED AN INDEPENDENT CONSULTANT TO REPRESENT ITS INTERESTS WITHIN THE ILLINOIS STATE GOVERNMENT, BEFORE BOTH THE LEGISLATIVE AND EXECUTIVE BRANCHES. PPSWG OPTED TO PAY A PROXY TAX IN LIEU OF REPORTING ANY MEMBERS' DUES AS NON-DEDUCTIBLE. 827339 797884 29455 29455 DUE TO MED-PROJECT USA 12803762 DUE TO MEMBERS 1982499 14786261 FORM 990, PART VI, SECTION A, LINE 1A THE EXECUTIVE COMMITTEE IS COMPRISED OF THE BOARD CHAIR, BOARD VICE CHAIR, BOARD SECRETARY/TREASURER AND PAST BOARD CHAIR. ALL MEMBERS OF THE EXECUTIVE COMMITTEE ARE CURRENT MEMBERS OF THE BOARD OF DIRECTORS. THE EXECUTIVE COMMITTEE SHALL POSSESS AND EXERCISE THE AUTHORITY OF THE BOARD OF DIRECTORS IN MANAGING PPSWG AFFAIRS BETWEEN BOARD MEETINGS. HOWEVER, THE EXECUTIVE COMMITTEE DOES NOT HAVE THE AUTHORITY TO: (I) AUTHORIZE DISTRIBUTIONS; (II) APPROVE OR PROPOSE TO THE MEMBERS ANY ACTION THAT REQUIRES MEMBER APPROVAL; (III) FILL VACANCIES ON THE BOARD OF DIRECTORS, ANY ADVISORY COMMITTEE, OR ANY TASK FORCE; OR (IV) ADOPT, AMEND, OR REPEAL THE BYLAWS OR ARTICLES OF INCORPORATION. FORM 990, PART VI, SECTION A, LINE 3 ASSOCIATION MANAGEMENT STRATEGIES, INC. PERFORMS MANAGEMENT AND OTHER PROFESSIONAL SERVICES ON BEHALF OF THE ORGANIZATION. FORM 990, PART VI, SECTION A, LINE 6 THE MEMBERSHIP OF PPSWG CONSISTS OF VOTING MEMBERS AND NON-VOTING MEMBERS. VOTING MEMBERS ARE MANUFACTURERS AND PRODUCERS OF PHARMACEUTICAL PRODUCTS AND/OR SHARPS, AND SUCH OTHER ENTITIES AS MAY BE DETERMINED BY THE PPSWG BOARD. VOTING MEMBERS ARE ENTITLED TO VOTE ON: (I) AMENDMENT OF THE BYLAWS OR PPSWG'S ARTICLES OF INCORPORATION; (II) ESTABLISHMENT OF ADDITIONAL MEMBERSHIP CLASSES; (III) ANY PROPOSED INCREASE IN PPSWG MEMBERSHIP DUES WHICH WOULD INCREASE THE FINANCIAL OBLIGATION OF THE MEMBERS TO WHOM SUCH INCREASE WOULD APPLY BY TWENTY PERCENT (20%) OR MORE COMPARED TO THE PRIOR YEAR; AND (IV) SETTING OF COST ALLOCATION FOR FEES. AN AFFILIATED FAMILY, WHICH IS DEFINED AS A COLLECTION OF A PARENT AND ALL SUBSIDIARY COMPANIES, OR ALL SUBSIDIARIES WITH A COMMON PARENT CORPORATION IS CONSIDERED A SINGLE MEMBER AND SHALL HAVE ONE (1) COLLECTIVE MEMBERSHIP VOTE. THERE ARE TWO CATEGORIES OF NON-VOTING MEMBERS: RETAIL PHARMACY MEMBERS AND ASSOCIATE PRODUCER MEMBERS. RETAIL PHARMACY MEMBERS ARE THOSE PHARMACIES THAT SELL PHARMACEUTICAL PRODUCTS DIRECTLY TO CONSUMERS OR PATIENTS AND THAT MEET CERTAIN CONDITIONS ESTABLISHED BY THE PPSWG BOARD FROM TIME TO TIME IN ITS SOLE DISCRETION. AT THE DISCRETION OF THE PPSWG BOARD, RETAIL PHARMACY MEMBERS MAY BE GRANTED MEMBERSHIP AT REDUCED COST OR NO PAYMENT OF PPSWG MEMBERSHIP AND/OR MED-PROJECT PROGRAM FEES. RETAIL PHARMACY MEMBERS DO NOT RECEIVE NOR ARE PERMITTED TO PARTICIPATE IN THE PPSWG WEEKLY BULLETIN, PPSWG MONTHLY MEMBER CALLS, PPSWG ANNUAL MEETINGS, AND SELECT PORTIONS OF THE PPSWG WEBSITE, AS DETERMINED BY THE PPSWG BOARD. RETAIL PHARMACY MEMBERS DO NOT HAVE ACCESS TO PPSWG COST ALLOCATION FORMULAS OR MODELS OR RELATED INFORMATION AND HAVE NO VOTING RIGHTS IN ANY MATTER COMING BEFORE THE MEMBERS OF PPSWG. EXCEPT AS DETERMINED BY THE PPSWG BOARD, RETAIL PHARMACY MEMBERS ARE NOT ELIGIBLE TO PARTICIPATE ON PPSWG OR MED-PROJECT BOARDS, COMMITTEES, OR TASK FORCES. ASSOCIATE PRODUCER MEMBERS ARE THOSE ENTITIES THAT ARE SUBJECT TO DRUGS OR SHARPS TAKE-BACK COMPLIANCE OBLIGATIONS IN JURISDICTIONS WHERE THEY ARE CONSIDERED COVERED ENTITIES PRODUCERS, MANUFACTURERS, OR COVERED MANUFACTURERS, OR OTHER ENTITIES THAT ARE REQUIRED TO PARTICIPATE IN DRUG OR SHARPS TAKE-BACK PROGRAMS, AND HAVE SUBMITTED A DRUGS AND/OR SHARPS STEWARDSHIP PLAN IN ANY JURISDICTIONS. ASSOCIATE PRODUCER MEMBERS DO NOT RECEIVE NOR ARE PERMITTED TO PARTICIPATE IN THE PPSWG WEEKLY BULLETIN, PPSWG MONTHLY MEMBER CALLS, PPSWG ANNUAL MEETINGS, AND SELECT PORTIONS OF THE PPSWG WEBSITE, AS DETERMINED BY THE PPSWG BOARD. ASSOCIATE PRODUCER MEMBERS DO NOT HAVE ACCESS TO PPSWG COST ALLOCATION FORMULAS OR MODELS OR RELATED INFORMATION AND HAVE NO VOTING RIGHTS IN ANY MATTER COMING BEFORE THE MEMBERS OF PPSWG. EXCEPT AS DETERMINED BY THE PPSWG BOARD, ASSOCIATE PRODUCER MEMBERS ARE NOT ELIGIBLE TO PARTICIPATE ON PPSWG OR MED-PROJECT BOARDS, COMMITTEES, OR TASK FORCES. FORM 990, PART VI, SECTION A, LINE 7A MEMBERS ELECT THE DIRECTORS; THE BOARD ELECTS THE OFFICERS. FORM 990, PART VI, SECTION A, LINE 7B THE BYLAWS ARTICLE III SECTION 13. VOTING RIGHTS: VOTING MEMBERS SHALL BE ENTITLED TO VOTE ON ALL MATTERS SUBMITTED TO A VOTE OF THE MEMBERSHIP BY THE BOARD OF DIRECTORS OR AS REQUIRED BY THESE BYLAWS OR THE ACT. IN ADDITION TO THE FOREGOING, VOTING MEMBERS SHALL BE ENTITLED TO VOTE ON THE FOLLOWING MATTERS: (I) AMENDMENT OF THESE BYLAWS OR PPSWG'S ARTICLES OF INCORPORATION; (II) ESTABLISHMENT OF ADDITIONAL MEMBERSHIP CLASSES; (III) ANY PROPOSED INCREASE IN PPSWG MEMBERSHIP DUES WHICH WOULD INCREASE THE FINANCIAL OBLIGATION OF THE MEMBERS TO WHOM SUCH INCREASE WOULD APPLY BY TWENTY PERCENT (20%) OR MORE COMPARED TO THE PRIOR YEAR; AND (IV) SETTING OF COST ALLOCATION FOR FEES. FORM 990, PART VI, SECTION B, LINE 11B PPSWG'S INDEPENDENT ACCOUNTANT PREPARES A DRAFT OF THE FORM 990 AND REVIEWS IT WITH PPSWG'S VP, FINANCE AND EXECUTIVE DIRECTOR. THE DRAFT FORM 990 IS PROVIDED TO THE EXECUTIVE COMMITTEE AND OUTSIDE LEGAL COUNSEL FOR REVIEW. THE EXECUTIVE COMMITTEE GIVES FINAL APPROVAL TO THE EXECUTIVE DIRECTOR TO FILE THE FORM 990 WITH THE IRS. THE FORM 990 IS THEN PRESENTED TO THE BOARD OF DIRECTORS FOR REVIEW BEFORE FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C THE ORGANIZATION REQUIRES FULL DISCLOSURE OF ALL ACTUAL AND POTENTIAL CONFLICTS OF INTEREST. EACH COVERED OFFICIAL SHALL DISCLOSE ANY AND ALL FACTS THAT MAY BE CONSTRUED AS A CONFLICT OF INTEREST. THE ORGANIZATION MANAGES ALL CONFLICTS OF INTEREST PURSUANT TO ITS BOARD-APPROVED CONFLICTS OF INTEREST POLICY. EACH BOARD MEMBER IS REQUIRED TO SIGN A CONFLICT-OF-INTEREST DISCLOSURE STATEMENT ANNUALLY. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. MED-PROJECT USA 1800 M STREET NW SUITE 400S WASHINGTON DC 20036 843694182 OPERATE MANDATED PHARMACEUTICAL PRODUCT AND SHARPS STEWARDSHIP PROGRAMS DC 501(C)(3) LINE 10 PPSWG 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 MED-PROJECT USA P 164315 INVOICED AMOUNT MED-PROJECT USA R 42417542 CASH COLLECTED